MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Macrophage Activation »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Macaca mulatta < Macrophage Activation < Macrophage Activation Syndrome  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000389 (2019) Yannick Degboé [France] ; Benjamin Rauwel [France] ; Michel Baron [France] ; Jean-Frédéric Boyer [France] ; Adeline Ruyssen-Witrand [France] ; Arnaud Constantin [France] ; Jean-Luc Davignon [France]Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism.
000691 (2018) Naoto Sakumura [Japon] ; Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Natsumi Inoue [Japon] ; Yasuo Nakagishi [Japon] ; Akihiro Yachie [Japon]Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
000982 (2017) Dae Hyun Yoo [Corée du Sud]Treatment of adult-onset still's disease: up to date.
000F45 (2016) Mark Wunderlich ; Courtney Stockman ; Mahima Devarajan ; Navin Ravishankar ; Christina Sexton ; Ashish R. Kumar [États-Unis] ; Benjamin Mizukawa ; James C. MulloyA xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment.
001159 (2015) Andreas Woerner [Suisse] ; Annette Von Scheven-Gête ; Rolando Cimaz ; Michaël HoferComplications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.
001602 (2013) David T. Teachey [États-Unis] ; Susan R. Rheingold ; Shannon L. Maude ; Gerhard Zugmaier ; David M. Barrett ; Alix E. Seif ; Kim E. Nichols ; Erica K. Suppa ; Michael Kalos ; Robert A. Berg ; Julie C. Fitzgerald ; Richard Aplenc ; Lia Gore ; Stephan A. GruppCytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.
001667 (2012) Masaki Shimizu [Japon] ; Yasuo Nakagishi ; Kazuko Kasai ; Yuichi Yamasaki ; Mari Miyoshi ; Syuji Takei ; Akihiro YachieTocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6.
001B77 (2007) Shumpei Yokota[Biologic response modifiers for juvenile idiopathic arthritis].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Macrophage Activation" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Macrophage Activation" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Macrophage Activation
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021